InvestSMART

Cryosite Limited (ASX:CTE)

ALERT: Price-sensitive ASX Announcement for CTE
Current share price for CTE : $1.200 -0.05 (-4%)+
Announcement
Release
13 Jul 2026 8:29AM
Price at Release
$1.250
Full Release
download
Summary
Cryosite Limited reported its unaudited financial results for the fiscal year ending 30 June 2026. The company experienced an 18% increase in revenue, reaching $16.7 million, and a 27% growth in EBITDA amounting to $4.3 million. This growth is attributed to enhanced capacity utilization at its Ferndell Street headquarters and improved margins. The company's outlook for FY2027 is positive, focusing on converting expanded capacity into client activity, supported by a strong client pipeline. The recent completion of the Ferndell Street cool room expansion and progress on the Adderley Street facility are expected to further bolster operations. The results are subject to the completion of the FY2026 audit process.
Key Points
  • Revenue increased by 18% to $16.7 million.
  • EBITDA grew by 27% to $4.3 million.
  • The company plans to leverage increased capacity for client activity in FY2027.
  • Ferndell Street cool room expansion completed.
  • Adderley Street facility build-out progressing well.
  • Strong client pipeline for FY2027.
  • Results are unaudited and pending audit completion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.